Is expanding HPV vaccination programs to include school-aged boys likely to be value-for-money: a cost-utility analysis in a country with an existing school-girl program

BACKGROUND: Similar to many developed countries, vaccination against human papillomavirus (HPV) is provided only to girls in New Zealand and coverage is relatively low (47% in school-aged girls for dose 3). Some jurisdictions have already extended HPV vaccination to school-aged boys. Thus, explorati...

Descripción completa

Detalles Bibliográficos
Autores principales: Pearson, Amber L, Kvizhinadze, Giorgi, Wilson, Nick, Smith, Megan, Canfell, Karen, Blakely, Tony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082618/
https://www.ncbi.nlm.nih.gov/pubmed/24965837
http://dx.doi.org/10.1186/1471-2334-14-351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082618/
https://www.ncbi.nlm.nih.gov/pubmed/24965837
http://dx.doi.org/10.1186/1471-2334-14-351

Ejemplares similares